In various cancer types, DAB2IP has been shown to control cell proliferation, apoptosis, and cell survival by inhibiting the Ras/MAPK pathway, activating the Ask1/JNK pathway, and inhibiting the PI3K/Akt pathway, respectively7,9,10. This evidence concerns the gene DAB2IP and cancer.